Data from both clinical and animal studies demonstrate the high sensitivity, specificity and safety of FOSB, GPAT3, RGCC and RNF43 for the diagnosis of NAFLD. The gene discussed is RNF43; the disease is metabolic dysfunction-associated steatotic liver disease.